INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2238072, encodeId=775d22380e2f7, content=两三个月了一直处于"Awaiting Reviewer Assignment"状态，这是送外审了还是一直没有被分配处理呢，发邮件给编辑也没有回复，要等文章毕业真的很着急，大家有遇到这个情况吗，该怎么处理呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f139072855, createdName=ms6000000157563137, createdTime=Wed Nov 20 21:35:42 CST 2024, time=2024-11-20, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2125494, encodeId=4ded2125494c9, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;生物学标记物 经验分享：各位大佬，Awaiting Reviewer Assignment的状态已经持续2周，是代表已经送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02812453676, createdName=123fdaafm54(暂无昵称), createdTime=Wed Apr 12 19:58:26 CST 2023, time=2023-04-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2216728, encodeId=9a6f2216e2819, content=满意, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=416c8642749, createdName=ms1000000442159001, createdTime=Thu Jul 25 01:13:16 CST 2024, time=2024-07-25, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2126594, encodeId=315a212659432, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：刚Awaiting Reviewer Selection，第二天的状态就变成了Awaiting Decision是不是要拒了，没有under Review这个状态。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02812453676, createdName=123fdaafm54(暂无昵称), createdTime=Mon Apr 17 21:47:11 CST 2023, time=2023-04-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1216516, encodeId=1ddd121651622, content=审稿速度:3.0 经验分享：19-Jan-2022提交 28-Jan-2022改格式后提交 28-Mar-2022小修 05-Apr-2022接收 29-Apr-2022可查, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88e65691792, createdName=ms9000000372271319, createdTime=Tue May 03 10:03:15 CST 2022, time=2022-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071766, encodeId=3b3d10e1766dd, content=Awaiting Reviewer Selection 是什么意思啊，送外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c6c25502009, createdName=ms9000002047508352, createdTime=Fri Nov 19 14:59:07 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115737, encodeId=db4a2115e37d4, content=偏重的研究方向：肿瘤 经验分享：需要原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b9e5636330, createdName=ms1000000882251215, createdTime=Tue Feb 21 16:21:43 CST 2023, time=2023-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193645, encodeId=02e4119364515, content=需要提交原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2691105351, createdName=zbwwh, createdTime=Tue Feb 15 16:22:51 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063799, encodeId=33f11063e99e3, content=多学，多问，审稿时间还好，多注意审稿人建议，这期刊可以的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName= 筝之韵, createdTime=Mon Oct 25 16:12:47 CST 2021, time=2021-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063798, encodeId=f42e1063e982d, content=经验分享：历时8个月顺利投稿，非常感谢网友老师的热心回复，很有帮助。我的经验还是要多看多问吧 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=海洋与蓝天, createdTime=Mon Oct 25 16:12:10 CST 2021, time=2021-10-25, status=1, ipAttribution=)]

2024-11-20 ms6000000157563137 来自安徽省

两三个月了一直处于"Awaiting Reviewer Assignment"状态，这是送外审了还是一直没有被分配处理呢，发邮件给编辑也没有回复，要等文章毕业真的很着急，大家有遇到这个情况吗，该怎么处理呢

71 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2238072, encodeId=775d22380e2f7, content=两三个月了一直处于"Awaiting Reviewer Assignment"状态，这是送外审了还是一直没有被分配处理呢，发邮件给编辑也没有回复，要等文章毕业真的很着急，大家有遇到这个情况吗，该怎么处理呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f139072855, createdName=ms6000000157563137, createdTime=Wed Nov 20 21:35:42 CST 2024, time=2024-11-20, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2125494, encodeId=4ded2125494c9, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;生物学标记物 经验分享：各位大佬，Awaiting Reviewer Assignment的状态已经持续2周，是代表已经送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02812453676, createdName=123fdaafm54(暂无昵称), createdTime=Wed Apr 12 19:58:26 CST 2023, time=2023-04-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2216728, encodeId=9a6f2216e2819, content=满意, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=416c8642749, createdName=ms1000000442159001, createdTime=Thu Jul 25 01:13:16 CST 2024, time=2024-07-25, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2126594, encodeId=315a212659432, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：刚Awaiting Reviewer Selection，第二天的状态就变成了Awaiting Decision是不是要拒了，没有under Review这个状态。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02812453676, createdName=123fdaafm54(暂无昵称), createdTime=Mon Apr 17 21:47:11 CST 2023, time=2023-04-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1216516, encodeId=1ddd121651622, content=审稿速度:3.0 经验分享：19-Jan-2022提交 28-Jan-2022改格式后提交 28-Mar-2022小修 05-Apr-2022接收 29-Apr-2022可查, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88e65691792, createdName=ms9000000372271319, createdTime=Tue May 03 10:03:15 CST 2022, time=2022-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071766, encodeId=3b3d10e1766dd, content=Awaiting Reviewer Selection 是什么意思啊，送外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c6c25502009, createdName=ms9000002047508352, createdTime=Fri Nov 19 14:59:07 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115737, encodeId=db4a2115e37d4, content=偏重的研究方向：肿瘤 经验分享：需要原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b9e5636330, createdName=ms1000000882251215, createdTime=Tue Feb 21 16:21:43 CST 2023, time=2023-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193645, encodeId=02e4119364515, content=需要提交原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2691105351, createdName=zbwwh, createdTime=Tue Feb 15 16:22:51 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063799, encodeId=33f11063e99e3, content=多学，多问，审稿时间还好，多注意审稿人建议，这期刊可以的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName= 筝之韵, createdTime=Mon Oct 25 16:12:47 CST 2021, time=2021-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063798, encodeId=f42e1063e982d, content=经验分享：历时8个月顺利投稿，非常感谢网友老师的热心回复，很有帮助。我的经验还是要多看多问吧 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=海洋与蓝天, createdTime=Mon Oct 25 16:12:10 CST 2021, time=2021-10-25, status=1, ipAttribution=)]

2023-04-12 123fdaafm54(暂无昵称) 来自广东省

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤;生物学标记物
经验分享：各位大佬，Awaiting Reviewer Assignment的状态已经持续2周，是代表已经送审了吗？

137 3 举报

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2238072, encodeId=775d22380e2f7, content=两三个月了一直处于"Awaiting Reviewer Assignment"状态，这是送外审了还是一直没有被分配处理呢，发邮件给编辑也没有回复，要等文章毕业真的很着急，大家有遇到这个情况吗，该怎么处理呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f139072855, createdName=ms6000000157563137, createdTime=Wed Nov 20 21:35:42 CST 2024, time=2024-11-20, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2125494, encodeId=4ded2125494c9, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;生物学标记物 经验分享：各位大佬，Awaiting Reviewer Assignment的状态已经持续2周，是代表已经送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02812453676, createdName=123fdaafm54(暂无昵称), createdTime=Wed Apr 12 19:58:26 CST 2023, time=2023-04-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2216728, encodeId=9a6f2216e2819, content=满意, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=416c8642749, createdName=ms1000000442159001, createdTime=Thu Jul 25 01:13:16 CST 2024, time=2024-07-25, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2126594, encodeId=315a212659432, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：刚Awaiting Reviewer Selection，第二天的状态就变成了Awaiting Decision是不是要拒了，没有under Review这个状态。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02812453676, createdName=123fdaafm54(暂无昵称), createdTime=Mon Apr 17 21:47:11 CST 2023, time=2023-04-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1216516, encodeId=1ddd121651622, content=审稿速度:3.0 经验分享：19-Jan-2022提交 28-Jan-2022改格式后提交 28-Mar-2022小修 05-Apr-2022接收 29-Apr-2022可查, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88e65691792, createdName=ms9000000372271319, createdTime=Tue May 03 10:03:15 CST 2022, time=2022-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071766, encodeId=3b3d10e1766dd, content=Awaiting Reviewer Selection 是什么意思啊，送外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c6c25502009, createdName=ms9000002047508352, createdTime=Fri Nov 19 14:59:07 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115737, encodeId=db4a2115e37d4, content=偏重的研究方向：肿瘤 经验分享：需要原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b9e5636330, createdName=ms1000000882251215, createdTime=Tue Feb 21 16:21:43 CST 2023, time=2023-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193645, encodeId=02e4119364515, content=需要提交原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2691105351, createdName=zbwwh, createdTime=Tue Feb 15 16:22:51 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063799, encodeId=33f11063e99e3, content=多学，多问，审稿时间还好，多注意审稿人建议，这期刊可以的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName= 筝之韵, createdTime=Mon Oct 25 16:12:47 CST 2021, time=2021-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063798, encodeId=f42e1063e982d, content=经验分享：历时8个月顺利投稿，非常感谢网友老师的热心回复，很有帮助。我的经验还是要多看多问吧 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=海洋与蓝天, createdTime=Mon Oct 25 16:12:10 CST 2021, time=2021-10-25, status=1, ipAttribution=)]

2024-07-25 ms1000000442159001 来自重庆

满意

78 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2238072, encodeId=775d22380e2f7, content=两三个月了一直处于"Awaiting Reviewer Assignment"状态，这是送外审了还是一直没有被分配处理呢，发邮件给编辑也没有回复，要等文章毕业真的很着急，大家有遇到这个情况吗，该怎么处理呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f139072855, createdName=ms6000000157563137, createdTime=Wed Nov 20 21:35:42 CST 2024, time=2024-11-20, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2125494, encodeId=4ded2125494c9, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;生物学标记物 经验分享：各位大佬，Awaiting Reviewer Assignment的状态已经持续2周，是代表已经送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02812453676, createdName=123fdaafm54(暂无昵称), createdTime=Wed Apr 12 19:58:26 CST 2023, time=2023-04-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2216728, encodeId=9a6f2216e2819, content=满意, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=416c8642749, createdName=ms1000000442159001, createdTime=Thu Jul 25 01:13:16 CST 2024, time=2024-07-25, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2126594, encodeId=315a212659432, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：刚Awaiting Reviewer Selection，第二天的状态就变成了Awaiting Decision是不是要拒了，没有under Review这个状态。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02812453676, createdName=123fdaafm54(暂无昵称), createdTime=Mon Apr 17 21:47:11 CST 2023, time=2023-04-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1216516, encodeId=1ddd121651622, content=审稿速度:3.0 经验分享：19-Jan-2022提交 28-Jan-2022改格式后提交 28-Mar-2022小修 05-Apr-2022接收 29-Apr-2022可查, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88e65691792, createdName=ms9000000372271319, createdTime=Tue May 03 10:03:15 CST 2022, time=2022-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071766, encodeId=3b3d10e1766dd, content=Awaiting Reviewer Selection 是什么意思啊，送外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c6c25502009, createdName=ms9000002047508352, createdTime=Fri Nov 19 14:59:07 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115737, encodeId=db4a2115e37d4, content=偏重的研究方向：肿瘤 经验分享：需要原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b9e5636330, createdName=ms1000000882251215, createdTime=Tue Feb 21 16:21:43 CST 2023, time=2023-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193645, encodeId=02e4119364515, content=需要提交原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2691105351, createdName=zbwwh, createdTime=Tue Feb 15 16:22:51 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063799, encodeId=33f11063e99e3, content=多学，多问，审稿时间还好，多注意审稿人建议，这期刊可以的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName= 筝之韵, createdTime=Mon Oct 25 16:12:47 CST 2021, time=2021-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063798, encodeId=f42e1063e982d, content=经验分享：历时8个月顺利投稿，非常感谢网友老师的热心回复，很有帮助。我的经验还是要多看多问吧 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=海洋与蓝天, createdTime=Mon Oct 25 16:12:10 CST 2021, time=2021-10-25, status=1, ipAttribution=)]

2023-04-17 123fdaafm54(暂无昵称) 来自广东省

审稿速度:2.0 | 投稿命中率:25.0
偏重的研究方向：肿瘤
经验分享：刚Awaiting Reviewer Selection，第二天的状态就变成了Awaiting Decision是不是要拒了，没有under Review这个状态。

137 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2238072, encodeId=775d22380e2f7, content=两三个月了一直处于"Awaiting Reviewer Assignment"状态，这是送外审了还是一直没有被分配处理呢，发邮件给编辑也没有回复，要等文章毕业真的很着急，大家有遇到这个情况吗，该怎么处理呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f139072855, createdName=ms6000000157563137, createdTime=Wed Nov 20 21:35:42 CST 2024, time=2024-11-20, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2125494, encodeId=4ded2125494c9, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;生物学标记物 经验分享：各位大佬，Awaiting Reviewer Assignment的状态已经持续2周，是代表已经送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02812453676, createdName=123fdaafm54(暂无昵称), createdTime=Wed Apr 12 19:58:26 CST 2023, time=2023-04-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2216728, encodeId=9a6f2216e2819, content=满意, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=416c8642749, createdName=ms1000000442159001, createdTime=Thu Jul 25 01:13:16 CST 2024, time=2024-07-25, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2126594, encodeId=315a212659432, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：刚Awaiting Reviewer Selection，第二天的状态就变成了Awaiting Decision是不是要拒了，没有under Review这个状态。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02812453676, createdName=123fdaafm54(暂无昵称), createdTime=Mon Apr 17 21:47:11 CST 2023, time=2023-04-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1216516, encodeId=1ddd121651622, content=审稿速度:3.0 经验分享：19-Jan-2022提交 28-Jan-2022改格式后提交 28-Mar-2022小修 05-Apr-2022接收 29-Apr-2022可查, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88e65691792, createdName=ms9000000372271319, createdTime=Tue May 03 10:03:15 CST 2022, time=2022-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071766, encodeId=3b3d10e1766dd, content=Awaiting Reviewer Selection 是什么意思啊，送外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c6c25502009, createdName=ms9000002047508352, createdTime=Fri Nov 19 14:59:07 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115737, encodeId=db4a2115e37d4, content=偏重的研究方向：肿瘤 经验分享：需要原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b9e5636330, createdName=ms1000000882251215, createdTime=Tue Feb 21 16:21:43 CST 2023, time=2023-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193645, encodeId=02e4119364515, content=需要提交原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2691105351, createdName=zbwwh, createdTime=Tue Feb 15 16:22:51 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063799, encodeId=33f11063e99e3, content=多学，多问，审稿时间还好，多注意审稿人建议，这期刊可以的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName= 筝之韵, createdTime=Mon Oct 25 16:12:47 CST 2021, time=2021-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063798, encodeId=f42e1063e982d, content=经验分享：历时8个月顺利投稿，非常感谢网友老师的热心回复，很有帮助。我的经验还是要多看多问吧 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=海洋与蓝天, createdTime=Mon Oct 25 16:12:10 CST 2021, time=2021-10-25, status=1, ipAttribution=)]

2022-05-03 ms9000000372271319

审稿速度:3.0
经验分享：19-Jan-2022提交
28-Jan-2022改格式后提交
28-Mar-2022小修
05-Apr-2022接收
29-Apr-2022可查

147 4 举报

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2238072, encodeId=775d22380e2f7, content=两三个月了一直处于"Awaiting Reviewer Assignment"状态，这是送外审了还是一直没有被分配处理呢，发邮件给编辑也没有回复，要等文章毕业真的很着急，大家有遇到这个情况吗，该怎么处理呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f139072855, createdName=ms6000000157563137, createdTime=Wed Nov 20 21:35:42 CST 2024, time=2024-11-20, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2125494, encodeId=4ded2125494c9, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;生物学标记物 经验分享：各位大佬，Awaiting Reviewer Assignment的状态已经持续2周，是代表已经送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02812453676, createdName=123fdaafm54(暂无昵称), createdTime=Wed Apr 12 19:58:26 CST 2023, time=2023-04-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2216728, encodeId=9a6f2216e2819, content=满意, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=416c8642749, createdName=ms1000000442159001, createdTime=Thu Jul 25 01:13:16 CST 2024, time=2024-07-25, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2126594, encodeId=315a212659432, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：刚Awaiting Reviewer Selection，第二天的状态就变成了Awaiting Decision是不是要拒了，没有under Review这个状态。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02812453676, createdName=123fdaafm54(暂无昵称), createdTime=Mon Apr 17 21:47:11 CST 2023, time=2023-04-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1216516, encodeId=1ddd121651622, content=审稿速度:3.0 经验分享：19-Jan-2022提交 28-Jan-2022改格式后提交 28-Mar-2022小修 05-Apr-2022接收 29-Apr-2022可查, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88e65691792, createdName=ms9000000372271319, createdTime=Tue May 03 10:03:15 CST 2022, time=2022-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071766, encodeId=3b3d10e1766dd, content=Awaiting Reviewer Selection 是什么意思啊，送外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c6c25502009, createdName=ms9000002047508352, createdTime=Fri Nov 19 14:59:07 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115737, encodeId=db4a2115e37d4, content=偏重的研究方向：肿瘤 经验分享：需要原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b9e5636330, createdName=ms1000000882251215, createdTime=Tue Feb 21 16:21:43 CST 2023, time=2023-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193645, encodeId=02e4119364515, content=需要提交原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2691105351, createdName=zbwwh, createdTime=Tue Feb 15 16:22:51 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063799, encodeId=33f11063e99e3, content=多学，多问，审稿时间还好，多注意审稿人建议，这期刊可以的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName= 筝之韵, createdTime=Mon Oct 25 16:12:47 CST 2021, time=2021-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063798, encodeId=f42e1063e982d, content=经验分享：历时8个月顺利投稿，非常感谢网友老师的热心回复，很有帮助。我的经验还是要多看多问吧 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=海洋与蓝天, createdTime=Mon Oct 25 16:12:10 CST 2021, time=2021-10-25, status=1, ipAttribution=)]

2021-11-19 ms9000002047508352

Awaiting Reviewer Selection 是什么意思啊，送外审了吗？

175 2 举报

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2238072, encodeId=775d22380e2f7, content=两三个月了一直处于"Awaiting Reviewer Assignment"状态，这是送外审了还是一直没有被分配处理呢，发邮件给编辑也没有回复，要等文章毕业真的很着急，大家有遇到这个情况吗，该怎么处理呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f139072855, createdName=ms6000000157563137, createdTime=Wed Nov 20 21:35:42 CST 2024, time=2024-11-20, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2125494, encodeId=4ded2125494c9, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;生物学标记物 经验分享：各位大佬，Awaiting Reviewer Assignment的状态已经持续2周，是代表已经送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02812453676, createdName=123fdaafm54(暂无昵称), createdTime=Wed Apr 12 19:58:26 CST 2023, time=2023-04-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2216728, encodeId=9a6f2216e2819, content=满意, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=416c8642749, createdName=ms1000000442159001, createdTime=Thu Jul 25 01:13:16 CST 2024, time=2024-07-25, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2126594, encodeId=315a212659432, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：刚Awaiting Reviewer Selection，第二天的状态就变成了Awaiting Decision是不是要拒了，没有under Review这个状态。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02812453676, createdName=123fdaafm54(暂无昵称), createdTime=Mon Apr 17 21:47:11 CST 2023, time=2023-04-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1216516, encodeId=1ddd121651622, content=审稿速度:3.0 经验分享：19-Jan-2022提交 28-Jan-2022改格式后提交 28-Mar-2022小修 05-Apr-2022接收 29-Apr-2022可查, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88e65691792, createdName=ms9000000372271319, createdTime=Tue May 03 10:03:15 CST 2022, time=2022-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071766, encodeId=3b3d10e1766dd, content=Awaiting Reviewer Selection 是什么意思啊，送外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c6c25502009, createdName=ms9000002047508352, createdTime=Fri Nov 19 14:59:07 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115737, encodeId=db4a2115e37d4, content=偏重的研究方向：肿瘤 经验分享：需要原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b9e5636330, createdName=ms1000000882251215, createdTime=Tue Feb 21 16:21:43 CST 2023, time=2023-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193645, encodeId=02e4119364515, content=需要提交原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2691105351, createdName=zbwwh, createdTime=Tue Feb 15 16:22:51 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063799, encodeId=33f11063e99e3, content=多学，多问，审稿时间还好，多注意审稿人建议，这期刊可以的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName= 筝之韵, createdTime=Mon Oct 25 16:12:47 CST 2021, time=2021-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063798, encodeId=f42e1063e982d, content=经验分享：历时8个月顺利投稿，非常感谢网友老师的热心回复，很有帮助。我的经验还是要多看多问吧 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=海洋与蓝天, createdTime=Mon Oct 25 16:12:10 CST 2021, time=2021-10-25, status=1, ipAttribution=)]

2023-02-21 ms1000000882251215

偏重的研究方向：肿瘤
经验分享：需要原始数据吗

149 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2238072, encodeId=775d22380e2f7, content=两三个月了一直处于"Awaiting Reviewer Assignment"状态，这是送外审了还是一直没有被分配处理呢，发邮件给编辑也没有回复，要等文章毕业真的很着急，大家有遇到这个情况吗，该怎么处理呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f139072855, createdName=ms6000000157563137, createdTime=Wed Nov 20 21:35:42 CST 2024, time=2024-11-20, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2125494, encodeId=4ded2125494c9, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;生物学标记物 经验分享：各位大佬，Awaiting Reviewer Assignment的状态已经持续2周，是代表已经送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02812453676, createdName=123fdaafm54(暂无昵称), createdTime=Wed Apr 12 19:58:26 CST 2023, time=2023-04-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2216728, encodeId=9a6f2216e2819, content=满意, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=416c8642749, createdName=ms1000000442159001, createdTime=Thu Jul 25 01:13:16 CST 2024, time=2024-07-25, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2126594, encodeId=315a212659432, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：刚Awaiting Reviewer Selection，第二天的状态就变成了Awaiting Decision是不是要拒了，没有under Review这个状态。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02812453676, createdName=123fdaafm54(暂无昵称), createdTime=Mon Apr 17 21:47:11 CST 2023, time=2023-04-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1216516, encodeId=1ddd121651622, content=审稿速度:3.0 经验分享：19-Jan-2022提交 28-Jan-2022改格式后提交 28-Mar-2022小修 05-Apr-2022接收 29-Apr-2022可查, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88e65691792, createdName=ms9000000372271319, createdTime=Tue May 03 10:03:15 CST 2022, time=2022-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071766, encodeId=3b3d10e1766dd, content=Awaiting Reviewer Selection 是什么意思啊，送外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c6c25502009, createdName=ms9000002047508352, createdTime=Fri Nov 19 14:59:07 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115737, encodeId=db4a2115e37d4, content=偏重的研究方向：肿瘤 经验分享：需要原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b9e5636330, createdName=ms1000000882251215, createdTime=Tue Feb 21 16:21:43 CST 2023, time=2023-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193645, encodeId=02e4119364515, content=需要提交原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2691105351, createdName=zbwwh, createdTime=Tue Feb 15 16:22:51 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063799, encodeId=33f11063e99e3, content=多学，多问，审稿时间还好，多注意审稿人建议，这期刊可以的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName= 筝之韵, createdTime=Mon Oct 25 16:12:47 CST 2021, time=2021-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063798, encodeId=f42e1063e982d, content=经验分享：历时8个月顺利投稿，非常感谢网友老师的热心回复，很有帮助。我的经验还是要多看多问吧 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=海洋与蓝天, createdTime=Mon Oct 25 16:12:10 CST 2021, time=2021-10-25, status=1, ipAttribution=)]

2022-02-15 zbwwh

需要提交原始数据吗

152 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2238072, encodeId=775d22380e2f7, content=两三个月了一直处于"Awaiting Reviewer Assignment"状态，这是送外审了还是一直没有被分配处理呢，发邮件给编辑也没有回复，要等文章毕业真的很着急，大家有遇到这个情况吗，该怎么处理呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f139072855, createdName=ms6000000157563137, createdTime=Wed Nov 20 21:35:42 CST 2024, time=2024-11-20, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2125494, encodeId=4ded2125494c9, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;生物学标记物 经验分享：各位大佬，Awaiting Reviewer Assignment的状态已经持续2周，是代表已经送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02812453676, createdName=123fdaafm54(暂无昵称), createdTime=Wed Apr 12 19:58:26 CST 2023, time=2023-04-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2216728, encodeId=9a6f2216e2819, content=满意, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=416c8642749, createdName=ms1000000442159001, createdTime=Thu Jul 25 01:13:16 CST 2024, time=2024-07-25, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2126594, encodeId=315a212659432, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：刚Awaiting Reviewer Selection，第二天的状态就变成了Awaiting Decision是不是要拒了，没有under Review这个状态。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02812453676, createdName=123fdaafm54(暂无昵称), createdTime=Mon Apr 17 21:47:11 CST 2023, time=2023-04-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1216516, encodeId=1ddd121651622, content=审稿速度:3.0 经验分享：19-Jan-2022提交 28-Jan-2022改格式后提交 28-Mar-2022小修 05-Apr-2022接收 29-Apr-2022可查, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88e65691792, createdName=ms9000000372271319, createdTime=Tue May 03 10:03:15 CST 2022, time=2022-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071766, encodeId=3b3d10e1766dd, content=Awaiting Reviewer Selection 是什么意思啊，送外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c6c25502009, createdName=ms9000002047508352, createdTime=Fri Nov 19 14:59:07 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115737, encodeId=db4a2115e37d4, content=偏重的研究方向：肿瘤 经验分享：需要原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b9e5636330, createdName=ms1000000882251215, createdTime=Tue Feb 21 16:21:43 CST 2023, time=2023-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193645, encodeId=02e4119364515, content=需要提交原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2691105351, createdName=zbwwh, createdTime=Tue Feb 15 16:22:51 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063799, encodeId=33f11063e99e3, content=多学，多问，审稿时间还好，多注意审稿人建议，这期刊可以的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName= 筝之韵, createdTime=Mon Oct 25 16:12:47 CST 2021, time=2021-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063798, encodeId=f42e1063e982d, content=经验分享：历时8个月顺利投稿，非常感谢网友老师的热心回复，很有帮助。我的经验还是要多看多问吧 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=海洋与蓝天, createdTime=Mon Oct 25 16:12:10 CST 2021, time=2021-10-25, status=1, ipAttribution=)]

2021-10-25  筝之韵

多学，多问，审稿时间还好，多注意审稿人建议，这期刊可以的

185 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2238072, encodeId=775d22380e2f7, content=两三个月了一直处于"Awaiting Reviewer Assignment"状态，这是送外审了还是一直没有被分配处理呢，发邮件给编辑也没有回复，要等文章毕业真的很着急，大家有遇到这个情况吗，该怎么处理呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f139072855, createdName=ms6000000157563137, createdTime=Wed Nov 20 21:35:42 CST 2024, time=2024-11-20, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2125494, encodeId=4ded2125494c9, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;生物学标记物 经验分享：各位大佬，Awaiting Reviewer Assignment的状态已经持续2周，是代表已经送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02812453676, createdName=123fdaafm54(暂无昵称), createdTime=Wed Apr 12 19:58:26 CST 2023, time=2023-04-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2216728, encodeId=9a6f2216e2819, content=满意, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=416c8642749, createdName=ms1000000442159001, createdTime=Thu Jul 25 01:13:16 CST 2024, time=2024-07-25, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2126594, encodeId=315a212659432, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：刚Awaiting Reviewer Selection，第二天的状态就变成了Awaiting Decision是不是要拒了，没有under Review这个状态。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02812453676, createdName=123fdaafm54(暂无昵称), createdTime=Mon Apr 17 21:47:11 CST 2023, time=2023-04-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1216516, encodeId=1ddd121651622, content=审稿速度:3.0 经验分享：19-Jan-2022提交 28-Jan-2022改格式后提交 28-Mar-2022小修 05-Apr-2022接收 29-Apr-2022可查, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88e65691792, createdName=ms9000000372271319, createdTime=Tue May 03 10:03:15 CST 2022, time=2022-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071766, encodeId=3b3d10e1766dd, content=Awaiting Reviewer Selection 是什么意思啊，送外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c6c25502009, createdName=ms9000002047508352, createdTime=Fri Nov 19 14:59:07 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115737, encodeId=db4a2115e37d4, content=偏重的研究方向：肿瘤 经验分享：需要原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b9e5636330, createdName=ms1000000882251215, createdTime=Tue Feb 21 16:21:43 CST 2023, time=2023-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193645, encodeId=02e4119364515, content=需要提交原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2691105351, createdName=zbwwh, createdTime=Tue Feb 15 16:22:51 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063799, encodeId=33f11063e99e3, content=多学，多问，审稿时间还好，多注意审稿人建议，这期刊可以的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName= 筝之韵, createdTime=Mon Oct 25 16:12:47 CST 2021, time=2021-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063798, encodeId=f42e1063e982d, content=经验分享：历时8个月顺利投稿，非常感谢网友老师的热心回复，很有帮助。我的经验还是要多看多问吧 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=海洋与蓝天, createdTime=Mon Oct 25 16:12:10 CST 2021, time=2021-10-25, status=1, ipAttribution=)]

2021-10-25 海洋与蓝天

经验分享：历时8个月顺利投稿，非常感谢网友老师的热心回复，很有帮助。我的经验还是要多看多问吧

173 0 举报

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务